126 participants
A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-15
- Start Date:
- 2026-05-28
- Completion:
- 2028-02-29
Conditions
- Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Interventions
- DRUG
No Results Yet